2010Journal watchRequires access

Abacavir/3TC vs. Tenofovir/FTC — Published Results from ACTG 5202

Abigail Zuger

Open publisher page 0 citations

Abstract

From September 2005 to November 2007, ACTG investigators enrolled 1858 HIV-infected, treatment-naive adults into a randomized trial comparing four

About this research paper

What this paper is about

From September 2005 to November 2007, ACTG investigators enrolled 1858 HIV-infected, treatment-naive adults into a randomized trial comparing four

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

From September 2005 to November 2007, ACTG investigators enrolled 1858 HIV-infected, treatment-naive adults into a randomized trial comparing four

Key concepts: Abacavir, Medicine, Tenofovir, Psychology, Pharmacology, Virology, Human immunodeficiency virus (HIV), Antiretroviral therapy

Related papers

Back to paper searchBrowse research topicsOriginal source
Abacavir/3TC vs. Tenofovir/FTC — Published Results from ACTG 5202 — Research Paper | ScholarLens